$TSHA 3 SEC Filings

Filed On	Filing
03 Nov 2023	Form 3: Long Alison S, Director No securities owned
26 Jun 2023	Form 3: Stalfort John A Iii, Director Holds 610,492 shares of Common Stock
31 Oct 2022	Form 3: Audentes Therapeutics, Inc., 10% owner and 1 other Holds 7,266,342 shares of Common Stock
24 Nov 2020	Form 3: Sepp-Lorenzino Laura, Director No securities owned
24 Nov 2020	Form 3: Reape Kathleen, Director No securities owned
23 Sep 2020	Form 3: Session R.a. Ii, Director Holds 9,148,402 shares of Common Stock
23 Sep 2020	Form 3: Prasad Suyash, CMO and Head of R&D
23 Sep 2020	Form 3: Nolan Sean P., Director
23 Sep 2020	Form 3: Nagendran Sukumar, Director
23 Sep 2020	Form 3: Manning Paul B, Director
23 Sep 2020	Form 3: Donenberg Phillip B., Director
23 Sep 2020	Form 3: Alam Kamran, Chief Financial Officer No securities owned

Comments